MRK - Merck & Co., Inc.
NYSE - NYSE Delayed price. Currency in USD
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
30/12/2018
30/12/2017
30/12/2016
30/12/2015
Cash flows from operating activities
Net income
9,314,000
6,220,000
2,568,000
5,691,000
4,442,000
Depreciation & amortisation
-
4,519,000
4,637,000
5,441,000
6,375,000
Deferred income taxes
-
-509,000
-2,621,000
-1,521,000
-764,000
Stock-based compensation
-
348,000
312,000
300,000
299,000
Change in working capital
-
-1,553,000
-5,021,000
-2,601,000
-268,000
Accounts receivable
-
-418,000
297,000
-619,000
-480,000
Inventory
-
-911,000
-145,000
206,000
805,000
Accounts payable
-
230,000
254,000
278,000
-37,000
Other working capital
-
8,307,000
4,559,000
8,762,000
11,138,000
Other non-cash items
-
1,628,000
769,000
938,000
1,437,000
Net cash provided by operating activities
-
10,922,000
6,447,000
10,376,000
12,421,000
Cash flows from investing activities
Investments in property, plant and equipment
-
-2,615,000
-1,888,000
-1,614,000
-1,283,000
Acquisitions, net
-
-431,000
-396,000
-780,000
-7,744,000
Purchases of investments
-
-7,994,000
-10,739,000
-15,651,000
-16,681,000
Sales/maturities of investments
-
15,252,000
15,664,000
14,353,000
20,413,000
Other investing activities
-
102,000
38,000
482,000
221,000
Net cash used for investing activities
-
4,314,000
2,679,000
-3,210,000
-4,758,000
Cash flows from financing activities
Debt repayment
-
-4,287,000
-1,103,000
-2,386,000
-2,906,000
Common stock issued
-
-
-
-
-
Common stock repurchased
-
-9,091,000
-4,014,000
-3,434,000
-4,186,000
Dividends paid
-
-5,172,000
-5,167,000
-5,124,000
-5,117,000
Other financing activities
-
-325,000
-195,000
-118,000
56,000
Net cash used provided by (used for) financing activities
-
-13,160,000
-10,006,000
-9,044,000
-5,270,000
Net change in cash
-
1,871,000
-423,000
-2,009,000
1,083,000
Cash at beginning of period
-
6,096,000
6,515,000
8,524,000
7,441,000
Cash at end of period
-
7,967,000
6,092,000
6,515,000
8,524,000
Free cash flow
Operating cash flow
-
10,922,000
6,447,000
10,376,000
12,421,000
Capital expenditure
-
-2,615,000
-1,888,000
-1,614,000
-1,283,000
Free cash flow
-
8,307,000
4,559,000
8,762,000
11,138,000